Hepatic expression of hepatocyte-growth-factor-like/macrophage-stimulating protein mRNA in fulminant hepatic failure

Lancet. 1994 Jul 2;344(8914):27-9. doi: 10.1016/s0140-6736(94)91050-2.

Abstract

We investigated whether impaired Kupffer cell phagocytosis in fulminant hepatic failure could be due to reduced synthesis of hepatocyte-growth-factor-like/macrophage-stimulating protein (HGFL/MSP), a serum protein synthesised predominantly in hepatocytes and required by tissue macrophages for phagocytosis. Hepatic expression of the 3.0 kb HGFL/MSP mRNA, assessed by northern hybridisation, was lower in nine patients with fulminant hepatic failure undergoing liver transplantation than in three liver grafts as controls (median absorbance units 97 [range 15-1200] versus 1114 [1100-1120], respectively; p < 0.05). Decreased hepatic HGFL/MSP production might cause impaired Kupffer cell phagocytosis in fulminant hepatic failure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Growth Substances / genetics
  • Growth Substances / metabolism*
  • Hepatic Encephalopathy / metabolism*
  • Hepatic Encephalopathy / physiopathology
  • Hepatic Encephalopathy / surgery
  • Hepatocyte Growth Factor*
  • Humans
  • Kupffer Cells / physiology
  • Liver / metabolism*
  • Liver Transplantation
  • Male
  • Phagocytosis
  • Proto-Oncogene Proteins*
  • RNA, Messenger / analysis

Substances

  • Growth Substances
  • Proto-Oncogene Proteins
  • RNA, Messenger
  • macrophage stimulating protein
  • Hepatocyte Growth Factor